Skip to content

Application of Esketamine intravenous anesthesia in elderly patients undergoing minor surgery

Esketamine intravenous anesthesia reduces the incidence of hypoxemia in elderly patients undergoing minor surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069175
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative hypoxemia

Interventions

Esketamine group:Esketamine
Control group:Intravenous sufentanil (5-10 µ g) Propofol (1-1.5 mg/kg) induced anesthesia.

Sponsors

Huadong Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients who plan to undergo intravenous anesthesia for minor surgery; (2) Those who are 65 years old or above, male or female, and have the ability to act independently; (3) The American Association of Anesthesiologists (ASA) is rated as I – III.

Exclusion criteria

Exclusion criteria: (1) Have a history of myocardial infarction and unstable angina pectoris in the past 6 months; (2) Have a history of severe arrhythmia, acute pharyngitis and tonsillitis; (3) Pneumonia or non-oxygen pulse blood oxygen saturation (SPO2)<90%; (4) Severe obstructive sleep apnea syndrome; (5) Allergies to propofol, eggs, soy or albumin; (6) Do not agree to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Blood oxygen saturation;

Secondary

MeasureTime frame
Incidence of severe hypoxemia;Duration of hypoxemia;lowest oxygen saturation;Proportion of emergency airway management;Operation time;recovery time;Satisfaction of anesthesiologists and surgeons;adverse event;

Countries

China

Contacts

Public ContactYIN, Xin

Huadong Hospital Affiliated to Fudan University

yinxin__2007@126.com+8613391113529

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026